Aarti Drugs LtdPharmaceuticalsINE767A01016Consolidated₹455.80-10.50 (-2.25%)
Valuation
Market Cap₹4.16K Cr
TTM PE18.20x
Forward PE16.59x
PEG0.92
Book Value₹169.70
P/B2.69x
TTM EPS₹25.05
Fwd EPS₹27.48
TTM Revenue₹2.85K Cr
TTM PAT₹228.71 Cr
TTM EBITDA₹384.39 Cr
TTM EBIT₹310.94 Cr
Last Qtr PAT₹82.77 Cr
Last Qtr EBITDA₹135.36 Cr
Last Qtr EBIT₹116.36 Cr
Profitability
ROE14.77%
ROCE14.78%
TTM NPM8.02%
TTM EBITDA %13.48%
Curr OPM9.99%
Last OPM7.12%
Curr NPM—
Last NPM—
Curr EPS₹9.07
Last EPS₹5.49
Balance sheet
Equity₹91.27 Cr
Reserve₹1.46K Cr
Total Debt₹576.83 Cr
D/E0.37x
Interest %11.63%
Curr Interest₹9.63 Cr
Price / range
Close₹455.80
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-2.25%
1W+1.76%
1M+8.27%
3M+10.08%
6M+15.14%
1Y-9.47%
2Y-5.74%
3Y-0.95%
5Y-20.98%
Diwali+9.42%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue706.28+22.0%627.45631.68528.80578.952,260.39
Other Income2.650.200.831.220.152.59
Total Income708.93+22.4%627.65632.51530.02579.102,262.98
Interest7.816.956.596.956.0126.38
Expenditure-632.20-20.8%-557.71-573.95-508.31-523.32-2,081.67
PBDT000000
EBITDA97.60+29.8%91.9079.2742.3175.19260.74
Depreciation-15.71-15.21-14.95-14.87-13.55-55.64
EBIT81.89+32.9%76.6964.3227.4461.64205.10
PBT76.73+37.6%67.8558.5621.7155.78181.31
Tax-19.05-17-13.6012.13-14-12.09
Equity91.2791.2791.270091.27
OPM10.8210.819.264.119.638.01
Net Profit57.68+38.1%50.8544.9633.8441.78169.22
NPM8.148.107.116.407.227.48
EPS6.32+38.0%5.574.933.714.5818.54

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,260.39+4.0%2,173.65-4.1%2,266.91-9.2%2,497.97+11.0%2,251.17+17.6%1,914.89
Other Income2.5913.584.182.234.776.42
Total Income2,262.98+3.5%2,187.23-3.7%2,271.09-9.2%2,500.20+10.8%2,255.94+17.4%1,921.31
Expenditure-2,081.67-4.7%-1,988.48+4.3%-2,078.61+9.4%-2,295.39-14.7%-2,000.44-26.3%-1,583.82
Interest-26.38-29.68-30.16-32.53-20.06-22.61
PBDT000000
EBITDA260.74-0.7%262.64-1.3%266.13-5.8%282.40-11.2%318.18-20.7%401.28
Depreciation-55.64-47.79-47.67-47.29-47.39-47.60
EBIT205.10-4.5%214.85-1.7%218.46-7.1%235.11-13.2%270.79-23.4%353.68
PBT181.31-8.8%198.75+3.3%192.48-6.0%204.81-19.8%255.50-24.3%337.71
Tax-12.09-41.44-50.60-52-60.50-80
Equity91.2791.270000
OPM (%)8.019.098.008.0011.0018.00
Net Profit169.22+7.6%157.31+10.9%141.88-7.2%152.81-21.6%195-24.3%257.71
NPM (%)7.487.196.006.009.0013.00
EPS (Rs)18.54+7.9%17.18+11.9%15.35-7.0%16.50-21.6%21.04-23.9%27.65
CEPS18.5417.1815.3516.5021.0427.65

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue826.24+26.6%702.78720.30601.71652.792,565.31
Other Income2.550.810.761.230.092.39
Total Income828.79+26.9%703.59721.06602.94652.882,567.70
Interest9.639.228.169.297.7033.71
Expenditure-719.51-21.4%-632.26-650.70-573.92-592.47-2,356.80
PBDT000000
EBITDA135.36+60.6%98.2095.8055.0384.28309.19
Depreciation-19-18.46-18.04-17.95-16.26-66.97
EBIT116.36+71.1%79.7477.7637.0868.02242.22
PBT109.28+80.9%69.2470.3629.0260.41210.90
Tax-26.51-19.11-15.1011.53-15.25-15.96
Equity91.2791.2791.270091.27
OPM13.199.849.764.819.258.21
Net Profit82.77+83.3%50.1355.2640.5545.16194.94
NPM9.997.127.666.736.927.59
EPS9.07+83.2%5.496.054.444.9521.36

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,565.31+7.5%2,387.03-5.6%2,528.58-6.9%2,716.05+9.1%2,488.65+15.5%2,154.78
Other Income2.3916.364.032.1911.324.53
Total Income2,567.70+6.8%2,403.39-5.1%2,532.61-6.8%2,718.24+8.7%2,499.97+15.8%2,159.31
Expenditure-2,356.80-7.5%-2,191.62+4.6%-2,297.08+7.9%-2,494.06-11.8%-2,230.01-24.5%-1,790.52
Interest-33.71-35.87-33.52-33.29-20.75-22.96
PBDT000000
EBITDA309.19+7.7%287.06-9.3%316.47+3.6%305.60-7.2%329.44-24.6%437.10
Depreciation-66.97-55.78-51.45-50.32-50.05-49.88
EBIT242.22+4.7%231.28-12.7%265.02+3.8%255.28-8.6%279.39-27.8%387.22
PBT210.90-0.4%211.77-10.1%235.53+5.1%224.18-17.0%269.96-26.8%369.01
Tax-15.96-43.67-63.94-57.82-64.96-88.61
Equity91.2791.270000
OPM (%)8.218.819.308.2510.8017.09
Net Profit194.94+16.0%168.10-2.0%171.59+3.1%166.36-18.8%205-26.9%280.40
NPM (%)7.596.996.786.128.2012.99
EPS (Rs)21.36+16.4%18.35-1.1%18.56+3.3%17.97-18.8%22.12-26.5%30.09
CEPS21.3618.3518.5617.9722.1230.09

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

29
YearTypeAmountEx-Date
2026Interim Dividend209 Feb 2026
2025Interim Dividend104 Feb 2025
2024Interim Dividend106 Feb 2024
2023Interim Dividend108 Feb 2023
2022Interim Dividend109 Feb 2022
2021Interim Dividend2.503 Nov 2020
2020Interim Dividend217 Feb 2020
2019Final Dividend126 Jul 2019
2018Final Dividend101 Aug 2018
2017Final Dividend109 Aug 2017
2016Interim Dividend322 Mar 2016
2016Interim Dividend1.512 Feb 2016
2016Interim Dividend2.2510 Nov 2015
2015Final Dividend305 Aug 2015
2015Interim Dividend504 Feb 2015
2015Interim Dividend519 Nov 2014
2014Final Dividend5.502 Jul 2014
2014Interim Dividend4.505 Feb 2014
2014Interim Dividend319 Nov 2013
2013Final Dividend424 Jul 2013
2013Interim Dividend311 Feb 2013
2013Interim Dividend305 Nov 2012
2012Final Dividend317 Aug 2012
2012Interim Dividend206 Feb 2012
2011Final Dividend2.514 Jul 2011
2011Interim Dividend2.507 Feb 2011
2010Final Dividend518 Aug 2010
2009Final Dividend323 Jul 2009
2008Final Dividend1.813 Aug 2008

Bonus

2
YearRatioEx-Date
20203:130 Sep 2020
20151:124 Mar 2015

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers